Literature DB >> 10506769

Clinical and angiographic follow-up after balloon angioplasty with provisional stenting for coronary in-stent restenosis.

S Elezi1, A Kastrati, M Hadamitzky, J Dirschinger, F J Neumann, A Schömig.   

Abstract

The objective of this study was to assess the angiographic and clinical outcome of patients with coronary in-stent restenosis treated with balloon angioplasty with provisional stenting. The study included 375 consecutive patients with in-stent restenosis managed with balloon angioplasty alone or combined with stenting. Clinical events were recorded during a 1-year follow-up period and quantitative analysis was performed on 6-month angiographic data. Of the 373 patients (451 lesions) with a successful procedure, 273 were treated with angioplasty alone and 100 with additional stenting. Target lesion revascularization was required in 23.7% of the patients: 20.7% in patients with angioplasty and 31.0% in patients with stenting. Angiographic restenosis rate was 38.9%: 35.8% in the angioplasty group and 47.7% in the stent group. Stenting in small vessels was associated with a much higher restenosis rate than in larger vessels (65.6% vs. 37.5%, respectively; P = 0.01). Thus, repeat balloon angioplasty with provisional stenting for in-stent restenosis is a safe treatment strategy associated with a relatively favorable long-term outcome. However, the long-term results might be improved if additional stenting is avoided especially in small vessels. Cathet. Cardiovasc. Intervent. 48:151-156, 1999. Copyright 1999 Wiley-Liss, Inc.

Entities:  

Mesh:

Year:  1999        PMID: 10506769     DOI: 10.1002/(sici)1522-726x(199910)48:2<151::aid-ccd6>3.0.co;2-c

Source DB:  PubMed          Journal:  Catheter Cardiovasc Interv        ISSN: 1522-1946            Impact factor:   2.692


  9 in total

Review 1.  Current understanding of coronary in-stent restenosis. Pathophysiology, clinical presentation, diagnostic work-up, and management.

Authors:  T M Schiele
Journal:  Z Kardiol       Date:  2005-11

2.  Superiority of sirolimus eluting stent compared with intracoronary beta radiation for treatment of in-stent restenosis: a matched comparison.

Authors:  E Iofina; P W Radke; P Skurzewski; P K Haager; R Blindt; K-C Koch; P Hanrath; J vom Dahl; R Hoffmann
Journal:  Heart       Date:  2005-03-29       Impact factor: 5.994

3.  Wingspan stents for the treatment of symptomatic atherosclerotic stenosis in small intracranial vessels: safety and efficacy evaluation.

Authors:  L Zhang; Q Huang; Y Zhang; J Liu; B Hong; Y Xu; W Zhao
Journal:  AJNR Am J Neuroradiol       Date:  2011-12-15       Impact factor: 3.825

4.  Reduction of intimal hyperplasia in injured rat arteries promoted by catheter balloons coated with polyelectrolyte multilayers that contain plasmid DNA encoding PKCδ.

Authors:  Shane L Bechler; Yi Si; Yan Yu; Jun Ren; Bo Liu; David M Lynn
Journal:  Biomaterials       Date:  2012-10-13       Impact factor: 12.479

5.  Polyelectrolyte multilayers promote stent-mediated delivery of DNA to vascular tissue.

Authors:  Eric M Saurer; Christopher M Jewell; Drew A Roenneburg; Shane L Bechler; Jose R Torrealba; Timothy A Hacker; David M Lynn
Journal:  Biomacromolecules       Date:  2013-05-02       Impact factor: 6.988

Review 6.  Drug-eluting stents: new era and new concerns.

Authors:  V Bhatia; R Bhatia; M Dhindsa
Journal:  Postgrad Med J       Date:  2004-01       Impact factor: 2.401

Review 7.  Nanoparticulate carriers for the treatment of coronary restenosis.

Authors:  Luis Brito; Mansoor Amiji
Journal:  Int J Nanomedicine       Date:  2007

8.  Switching types of drug-eluting stents does not prevent repeated in-stent restenosis in patients with coronary drug-eluting stent restenosis.

Authors:  Yuhei Nojima; Yoshinori Yasuoka; Kiyoshi Kume; Hidenori Adachi; Susumu Hattori; Ryo Matsutera; Yasuaki Kohama; Tatsuya Sasaki
Journal:  Coron Artery Dis       Date:  2014-12       Impact factor: 1.439

Review 9.  Health Care Monitoring and Treatment for Coronary Artery Diseases: Challenges and Issues.

Authors:  Mokhalad Alghrairi; Nasri Sulaiman; Saad Mutashar
Journal:  Sensors (Basel)       Date:  2020-08-01       Impact factor: 3.576

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.